{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:35:02Z","timestamp":1788986102913,"version":"build-2803163510"},"reference-count":47,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12,1]]},"DOI":"10.1210\/jc.2009-1674","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T02:47:55Z","timestamp":1257389275000},"page":"4938-4945","source":"Crossref","is-referenced-by-count":59,"title":["Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial"],"prefix":"10.1210","volume":"94","author":[{"given":"Beata","family":"Banaszewska","sequence":"first","affiliation":[{"name":"Division of Infertility and Reproductive Endocrinology (B.B., L.P., R.Z.S.), Department of Gynecology, Obstetrics, and Gynecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Pawelczyk","sequence":"additional","affiliation":[{"name":"Division of Infertility and Reproductive Endocrinology (B.B., L.P., R.Z.S.), Department of Gynecology, Obstetrics, and Gynecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Z.","family":"Spaczynski","sequence":"additional","affiliation":[{"name":"Division of Infertility and Reproductive Endocrinology (B.B., L.P., R.Z.S.), Department of Gynecology, Obstetrics, and Gynecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni J.","family":"Duleba","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility (A.J.D.), Department of Ob\/Gyn, University of California Davis, Sacramento, California 95817"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113451753200_R1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncio\u0301n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction.","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t2019041113451753200_R5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113451753200_R7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinchem\/36.2.283","article-title":"Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgens.","volume":"36","author":"Wild","year":"1990","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113451753200_R8","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome.","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome.","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041113451753200_R10","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R11","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajog.2005.11.009","article-title":"Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin.","volume":"194","author":"Banaszewska","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113451753200_R13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome\u2014a randomised, double-blind, placebo-controlled trial.","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041113451753200_R14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome.","volume":"152","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113451753200_R15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113451753200_R16","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.","volume":"92","author":"Luque-Rami\u0301rez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","article-title":"Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial.","volume":"85","author":"Duleba","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113451753200_R18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jc.2008-1750","article-title":"The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.","volume":"94","author":"Sathyapalan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R20","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113451753200_R22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions.","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041113451753200_R23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113451753200_R25","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R26","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113451753200_R27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway.","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113451753200_R28","first-page":"2761","article-title":"Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.","volume":"20","author":"Bouterfa","year":"2000","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t2019041113451753200_R29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/mol.59.3.646","article-title":"Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.","volume":"59","author":"Wassmann","year":"2001","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t2019041113451753200_R30","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1210\/endo-124-5-2297","article-title":"Mevinolin (lovastatin) inhibits androstenedione production by porcine ovarian theca cells at the level of the 17 \u03b1-hydroxylase:C-17,20-lyase complex.","volume":"124","author":"Engelhardt","year":"1989","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"key\n\t\t\t\t2019041113451753200_R31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","article-title":"Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis","volume":"82","author":"Izquierdo","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113451753200_R32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so called \u201chyperthecosis.\u201d","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t2019041113451753200_R33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome.","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113451753200_R34","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1994.tb02577.x","article-title":"Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113451753200_R36","first-page":"1229","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol 174:1224\u20131229; discussion"},{"key":"key\n\t\t\t\t2019041113451753200_R37","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113451753200_R38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/BF02374502","article-title":"Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.","volume":"36","author":"Nielsen","year":"1993","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113451753200_R39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041113451753200_R40","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/humrep\/15.6.1266","article-title":"Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.","volume":"15","author":"Morin-Papunen","year":"2000","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113451753200_R41","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R42","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1210\/jc.2005-0965","article-title":"Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.","volume":"90","author":"Orio Jr","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113451753200_R43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113451753200_R44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action.","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113451753200_R45","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1161\/01.RES.0000257747.74358.1c","article-title":"Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1","volume":"100","author":"Fisslthaler","year":"2007","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019041113451753200_R46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113451753200_R47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.30386","article-title":"Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins.","volume":"131","author":"Edison","year":"2004","journal-title":"Am J Med Genet A"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/12\/4938\/11059874\/jcem4938.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T12:57:47Z","timestamp":1710680267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/12\/4938\/2596961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,1]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-1674","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,1]]}}}